What does Optifarm do?

Optifarm is a pharmacy in Zottegem. Private Limited, started on 28 December 1970, 1 establishment.

What is the address of Optifarm?

The registered office of Optifarm is located at Heldenlaan 16, 9620 Zottegem.

Is Optifarm still active?

Yes. According to the CBE (29 October 2026) Optifarm is active, legal situation “Normale toestand”, started on 28 December 1970.

Is Optifarm registered on Peppol?

Yes, Optifarm is registered on the Peppol network with ID 0208:0407818781.

What is the enterprise number of Optifarm?

The enterprise number of Optifarm is BE0407818781.

When was Optifarm founded?

Optifarm was founded on 28 December 1970.

Who are the directors of Optifarm?

According to the 2025 annual accounts, the directors of Optifarm are: Groep Melida BV.

Is Optifarm a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 December 1970; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Optifarm make in 2025?

Optifarm posted a profit after taxes of € 71,877 in financial year 2025.

What is the revenue of Optifarm?

As a small company, Optifarm is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 584,204.

How much does an employee at Optifarm earn?

The average wage cost per full-time employee at Optifarm was € 125,600 in 2025: staff costs of € 301,467 for 2.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Optifarm have?

According to the 2025 annual accounts, Optifarm has 2.4 full-time equivalents (FTE).

Optifarm (Private Limited) - Zottegem - BE0407818781

Dossier Optifarm, printed on 29 October 2026 from databakkes.be/en/0407818781/optifarm. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 42 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Optifarm from Zottegem, company number BE0407818781, closed financial year 2025 with a result of € 71,877 after tax. For that financial year Optifarm recorded a gross margin of € 584,204 and equity of € 412,960. Compared with financial year 2024, the result moved from € 55,429 to € 71,877. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.

What it is worth Healthy

€ 412,960

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 71,877

▲ 30% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 81,300

▼ 44% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 71,877 paid out

100 % of the profit went to the shareholders, mostly to GROEP MELIDA (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.4

▲ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 301,467

▲ 72% vs 2024

€ 125,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 7,073

▼ 31% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 15 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.5 million

▲ 3% vs 2024

€ 95,122 is repaid this year. At this pace the long-term loan is gone in ≈ 15 years.

Owed to suppliers

€ 432,821

▲ 32% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 17,923

▼ 19% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 413,461 Gross margin 2022: € 413,461 First fiscal year in the series	€ 322,467 Gross margin 2023: € 322,467 ▼ 22% vs 2022 (€ 413,461) Unfavourable step	€ 398,913 Gross margin 2024: € 398,913 ▲ 24% vs 2023 (€ 322,467) Favourable step	€ 584,204 Gross margin 2025: € 584,204 ▲ 46% vs 2024 (€ 398,913) Favourable step	▲ 46%
Profit after taxes	€ 198,497 Profit after taxes 2022: € 198,497 First fiscal year in the series	€ 58,698 Profit after taxes 2023: € 58,698 ▼ 70% vs 2022 (€ 198,497) Unfavourable step	€ 55,429 Profit after taxes 2024: € 55,429 ▼ 6% vs 2023 (€ 58,698) Unfavourable step	€ 71,877 Profit after taxes 2025: € 71,877 ▲ 30% vs 2024 (€ 55,429) Favourable step	▲ 30%
Equity	€ 432,960 Equity 2022: € 432,960 First fiscal year in the series	€ 412,960 Equity 2023: € 412,960 ▼ 5% vs 2022 (€ 432,960) Unfavourable step	€ 412,960 Equity 2024: € 412,960 Unchanged (€ 412,960) Unchanged	€ 412,960 Equity 2025: € 412,960 Unchanged (€ 412,960) Unchanged
Total debts	€ 644,327 Total debts 2022: € 644,327 First fiscal year in the series	€ 898,539 Total debts 2023: € 898,539 ▲ 39% vs 2022 (€ 644,327) Unfavourable step	€ 1,887,994 Total debts 2024: € 1,887,994 ▲ 110% vs 2023 (€ 898,539) Unfavourable step	€ 2,047,323 Total debts 2025: € 2,047,323 ▲ 8% vs 2024 (€ 1,887,994) Unfavourable step	▲ 8%
Cash	€ 412,036 Cash 2022: € 412,036 First fiscal year in the series	€ 61,635 Cash 2023: € 61,635 ▼ 85% vs 2022 (€ 412,036) Unfavourable step	€ 145,810 Cash 2024: € 145,810 ▲ 137% vs 2023 (€ 61,635) Favourable step	€ 81,300 Cash 2025: € 81,300 ▼ 44% vs 2024 (€ 145,810) Unfavourable step	▼ 44%
Land & buildings	-	€ 798,826 Land & buildings 2023: € 798,826 First fiscal year in the series	€ 1,175,352 Land & buildings 2024: € 1,175,352 ▲ 47% vs 2023 (€ 798,826) Unchanged	€ 1,139,906 Land & buildings 2025: € 1,139,906 ▼ 3% vs 2024 (€ 1,175,352) Unchanged	▼ 3%
Retained profit	€ 394,210 Retained profit 2022: € 394,210 First fiscal year in the series	€ 374,210 Retained profit 2023: € 374,210 ▼ 5% vs 2022 (€ 394,210) Unfavourable step	€ 374,210 Retained profit 2024: € 374,210 Unchanged (€ 374,210) Unchanged	€ 374,210 Retained profit 2025: € 374,210 Unchanged (€ 374,210) Unchanged
Dividend	€ 84,000 Dividend 2022: € 84,000 First fiscal year in the series	€ 78,698 Dividend 2023: € 78,698 ▼ 6% vs 2022 (€ 84,000) Unchanged	€ 55,429 Dividend 2024: € 55,429 ▼ 30% vs 2023 (€ 78,698) Unchanged	€ 71,877 Dividend 2025: € 71,877 ▲ 30% vs 2024 (€ 55,429) Unchanged	▲ 30%
Bank debt	€ 107,389 Bank debt 2022: € 107,389 First fiscal year in the series	€ 673,617 Bank debt 2023: € 673,617 ▲ € 566,229 vs 2022 (€ 107,389) Unfavourable step	€ 1,459,927 Bank debt 2024: € 1,459,927 ▲ 117% vs 2023 (€ 673,617) Unfavourable step	€ 1,504,113 Bank debt 2025: € 1,504,113 ▲ 3% vs 2024 (€ 1,459,927) Unfavourable step	▲ 3%
Balance sheet total	€ 1,077,286 Balance sheet total 2022: € 1,077,286 First fiscal year in the series	€ 1,311,499 Balance sheet total 2023: € 1,311,499 ▲ 22% vs 2022 (€ 1,077,286) Unchanged	€ 2,300,954 Balance sheet total 2024: € 2,300,954 ▲ 75% vs 2023 (€ 1,311,499) Unchanged	€ 2,460,283 Balance sheet total 2025: € 2,460,283 ▲ 7% vs 2024 (€ 2,300,954) Unchanged	▲ 7%
Employees (FTE)	2.1 Employees (FTE) 2022: 2.1 First fiscal year in the series	2.1 Employees (FTE) 2023: 2.1 Unchanged (2.1) Unchanged	2.2 Employees (FTE) 2024: 2.2 ▲ 0.1 vs 2023 (2.1) Unchanged	2.4 Employees (FTE) 2025: 2.4 ▲ 0.2 vs 2024 (2.2) Unchanged	▲ 0.2

Key figures of Optifarm, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Optifarm?

What happened at Optifarm in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 15, 2026 New annual accounts for financial year 2025: profit of € 71,877 (▲ 30% vs 2024). Source: NBB ↗
2021 Groep Melida BV became a director. NBB
Jan 1, 1971 New establishment in Zottegem. KBO
Dec 28, 1970 Start of the company according to the CBE. KBO

In short

From € 198,497 profit in 2022 to € 71,877 profit in 2025.

Paid € 89,820 in corporate taxes since 2022.

Best year ever: 2022, with € 198,497 profit.

On average € 243,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

GROEP MELIDA 100%

The stake of GROEP MELIDA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Optifarm

Behind Optifarm is Groep Melida BV. The shares are held by GROEP MELIDA (100%).

Directors

According to the 2025 annual accounts

Groep Melida BV

Bestuurder · represented by Daan Blomme

since 2021

Shareholders

GROEP MELIDA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Heldenlaan 16

9620 Zottegem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Studiecentrum voor Kontaktlenzenaanpassing

Vereniging van medeëigenaars van de RESIDENTIE H16, Heldenlaan 16 te 9620 Zottegem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0407.818.781

VAT number

BE 0407.818.781

Registered office

Heldenlaan 16, 9620 Zottegem

Names & denominations

Optifarm

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

28 December 1970

Peppol

Active · Active since 20 Dec 2024

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Detailhandel in corrigerende brillen, lenzen en zonnebrillen

Gespecialiseerde detailhandel in optische en fotografische artikelen, foto- en filmapparatuur, optische en precisie-instrumenten

Detailhandel in fotografische en optische artikelen en in precisieinstrumenten in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

Optifarm

Warning lights

Financials

What happened to Optifarm?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions